Neoplasms

3,880 trials 1,551 recruiting

Filter these 3,880 trials by phase, country and sponsor.

Open in Search →

A Phase 1 study to evaluate IK-930 in subjects with advanced solid tumors Ended

2022-502622-40-00 Advanced Solid Tumors 1
Study of the Effectiveness and Safety of Acasunlimab Alone or With Pembrolizumab in treating Advanced Melanoma of the Skin That Has Returned… Ended

2025-520468-16-00 Cutaneous Melanoma, Relapsed/Refractory, Locally Advanc 4
COMPRENDO - A PHASE II OPEN LABEL STUDY FOR THE COMPREHENSIVE ANALYSIS OF PREDICTORS OF THE TREATMENT WITH PEMBROLIZUMAB AND OLAPARIB IN PAT… Ended

2024-519350-37-00 patients with unresectable or metastatic HER2 negative 4
A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients with Advanced Gastro… Ended

2022-502087-21-00 Gastrointestinal Stromal Tumors (GIST) 7
DCC-3084 monotherapy in patients with solid tumors Ended

2024-517829-12-00 Solid tumors driven by the MAPK Pathway 7
A Phase 3 Study to Evaluate the Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants with Relapsed or Ref… Ended

2023-509472-42-00 Relapsed and/or Refractory Multiple Myeloma 5
Surgical or radiotherapeutic intervention concerning large singular stable to progressive metastases in patients with BRAFV600-mutated melan… Ended

2024-516073-74-00 Unresectable or metastatic melanoma with a BRAF V600 mu 6
A study to evaluate the safety and efficacy of mebendazole in combination with low-dose Ara-C in elderly patients with relapsed/refractory a… Ended

2024-518363-36-00 relapsed/refractory acute myeloid leukemia 4
A Phase I Study of INCB099280 in Combination With Ipilimumab in Participants With Selected Solid Tumors Ended

2023-503243-34-00 Solid tumor 3
LSTA1 Phase 2a basket trial in advanced solid tumors Ended

2023-503740-14-00 Head and neck cancer 4
A Phase 1/2 Study of DCC-3116 in Patients With MAPK Pathway Mutant Solid Tumors Ended

2022-501474-19-00 Non-Small Cell Lung Cancer 7
A Study Testing a New Drug (ALT-803) With BCG to Treat Early-Stage Bladder Cancer Ended

2025-521223-78-00 Non-Muscle Invasive Bladder Cancer 4
A Phase 1/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Ac… Ended

2024-515258-25-00 advanced solid tumors with KRAS G12C mutation 7
SPECT/CT imaging of FPI-2505 in patients with solid tumours; a phase 0 molecular imaging basket trial (SCOPE-study). Ended

2025-521235-37-00 small cell lung cancer, non-smallcell lung cancer, colo 1
A Phase II, open label, single arm, multicentre study on THOracic Radiotherapy in Extensive Stage SCLC patients submitted to first line CHT-… Ended

2024-517445-13-00 Extended stage small cell lung cancer patients confirme 4
APRILIAH (Aprogen Phase III Clinical Trial to Compare Efficacy, Safety, and Immunogenicity of AP063 in Subjects with HER2+ Breast Cancer) Ended

2023-506975-83-00 HER2-positive metastatic breast cancer (MBC) and early 5
Trial assessing the efficacy of suraparib as first line therapy for patients with metastatic homologous repair-deficient pancreatic cancer Ended

2024-516558-24-00 Pancreatic (PAAD) 4
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advan… Ended

2023-506487-13-00 Hormone receptor-positive, her2-negative advanced/metas 5
Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Partici… Ended

2024-512586-13-00 Non-Hodgkin's Lymphoma 1
An open label phase II basket trial exploring the efficacy and safety of the combination of Niraparib and Dostarlimab in patients with DNA r… Ended

2024-514855-13-00 DNA repair-deficient or platinum-sensitive solid tumors 4
Precision therapy versus standard therapy in Acute Myeloid Leukaemia and Myelodysplastic syndrome in elderly (PALM) – a phase II randomized … Ended

2023-509092-16-00 Chronic myelomonocyte leukemia 4
A Phase 2 Study of Tremelimumab (Day 1 only), Durvalumab (MEDI4736) and Trans-arterial catheter chemoembolization (TACE)in patients with adv… Ended

2023-510117-26-00 Advanced Hepatocellular Carcinoma (HCC) 4
Pembrolizumab Alone versUs pembrolizumab-chemotherapy in first LInE NSCLC (PAULIEN) Ended

2024-516581-11-00 Advanced stage NSCLC 5
Study to Assess the Safety, Tolerability and Efficacy of Lurbinectedin and Dostarlimab treatment in patients with endometrial cancer after d… Ended

2023-508583-30-00 Advanced/Recurrent Endometrial Cancer Patients with Dis 9